When was Evogene founded?

Evogene was founded in 2002 and raised its 1st funding round 6 years after it was founded.

Where is Evogene located?

Evogene is headquartered in Rehovot, Israel. It is registered at 13, גד פינשטיין, רחובות.

How many employees does Evogene have?

As of May 31, 2026, the latest employee count at Evogene is 102.

Is Evogene a funded company?

Evogene is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Apr 30, 2008.

When was the latest funding round of Evogene?

Evogene's latest funding was a $***** Grant (prize money) round on May 09, 2023, with participation from 0 investor.

What is the annual revenue of Evogene?

Annual revenue of Evogene is $8.51M as on Dec 31, 2024.

Where does Evogene rank among its competitors?

Evogene ranks 8th amongst 291 active competitors, of which 81 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Tropic Biosciences, which secured $105M in Mar, 2026.

Who are the top competitors of Evogene?

Evogene's top competitors include Advanta, Tropic Biosciences and Cibus. Among them, Tropic Biosciences secured the most recent funding round in March, 2026.

Evogene - 2026 Company Profile, Funding, Competitors & Financials

Evogene is a public company based in Rehovot (Israel), founded in 2002. It operates as a Developer of computational tools for pharmaceutical and agricultural industries. Evogene has raised an undisclosed amount in funding. The company has 291 active competitors, including 81 funded and 46 that have exited. Its top competitors include companies like Advanta, Tropic Biosciences and Cibus.

Company Details

Developer of computational tools for pharmaceutical and agricultural industries. The company utilizes generative artificial intelligence to design small molecules optimized for multiple parameters. These molecules increase the probability of success while reducing time and costs. The business facilitates the development of market-ready products for drug discovery and agricultural chemicals through strategic partnerships and in-house expertise.

Website: evogene.com
Social
Email ID: *****@evogene.com
Phone Number: +972 **********
Registered Address: 13, גד פינשטיין, רחובות

Key Metrics

Founded Year

2002

Location

Rehovot, Israel

Stage

Public

Latest Funding Round

Grant (prize money), May 09, 2023, $*****

Investors

Shavit Capital & 5 more

Ranked

8^th among 291 active competitors

Annual Revenue

$8.51M as on Dec 31, 2024

Employee Count

102 as on May 31, 2026

Similar Companies

Advanta & 335 more

Exit Details

Public

View Evogene's full profile

Evogene is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Evogen Ltd. CIN: 512838723 , Israel, Active	Oct 10, 1999	$8.51M (As on Dec 31, 2024)	-	-

Evogene got listed on Mar 17, 2008.

Click here to take a look at Evogene's IPO in detail

Evogene has raised funding over 4 rounds. Its first funding round was on Apr 30, 2008. Evogene has 6 institutional investors.

Here is the list of recent funding rounds of Evogene:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 09, 2023	7645157	Grant (prize money)	1733969	1604499	6380665	4290036
May 01, 2023	6975252	Grant (prize money)	5619379	2792395	2440525	Europa
Jan 01, 2016	4802686	Grant (prize money)	8508371	3225789	5510911	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Evogene's funding rounds and investors

Evogene's employee count trend

Evogene has 102 employees as of May 26. Here is Evogene's employee count trend over the years:

Uncover Evogene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Evogene include Advanta, Tropic Biosciences and Cibus. Here is the list of Top 10 competitors of Evogene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Advanta 1989, Dubai (United Arab Emirates), Public	Developer of high-nutrition crops for sustainable agriculture	$400M	KKR, Paine Schwartz Partners & 5 others	70/100
2nd	Tropic Biosciences 2016, Norwich (United Kingdom), Series C	Developer of gene editing technologies for improved tropical crop production	$179M	Temasek, Aliment Capital & 39 others	68/100
3rd	Cibus 2001, San Diego (United States), Public	Developer of precision breeding technologies for resilient and vigorous crops	$34.5M	Fidelity Investments, Qubis & 7 others	64/100
4th	Pairwise 2017, Durham (United States), Series C	Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops	$155M	Deerfield, Monsanto & 5 others	64/100
5th	Phylos Bioscience 2014, Portland (United States), Series B	Developer of cannabis F1 hybrid seeds and natural THC products	$31.7M	Merida Capital Partners, Entourage Effect Capital ... & 6 others	60/100
6th	Nuziveedu Seeds 1973, Hyderabad (India), Late Stage	Provider of breeding programs that genetically enhance crops for substantial gains	$105M	Blackstone, BIRAC & 9 others	59/100
7th	Benson Hill 2012, St. Louis (United States), Deadpooled	Developer of soybean genetics, seeds, and related programs for agriculture	$407M	Google Ventures, Lewis & Clark Agrifood & 32 others	59/100
8th	Evogene 2002, Rehovot (Israel), Public	Developer of computational tools for pharmaceutical and agricultural industries	-	Shavit Capital, GlenRock Israel & 4 others	58/100
9th	Renaissance BioScience 2013, Vancouver (Canada), Series A	Developer of bioengineering technology for agriculture, food, health, and industrial markets	$5M	Northview LifeSciences, Carpere Capital Management ... & 2 others	57/100
10th	Ohalo 2019, Aptos (United States), Series C	Developer of plant breeding systems for potatoes, almonds, and strawberries	$40M	-	57/100